The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells | PLOS ONE
Synthesis and biological evaluation of geldanamycin–ferulic acid conjugate as a potent Hsp90 inhibitor - RSC Advances (RSC Publishing) DOI:10.1039/C9RA08665J
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90 | PNAS
Ganetespib: research and clinical development | OTT
APExBIO - 17-AAG (KOS953)|Hsp90 inhibitor|CAS# 75747-14-7
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development | Oncogene
Examples of Hsp90 N-terminal inhibitors in clinical trials. | Download Scientific Diagram
Tanespimycin - an overview | ScienceDirect Topics
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90 | PNAS
Pharmaceuticals | Free Full-Text | Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies | HTML
Frontiers | A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells | Oncology
Hsp90 Chaperone Inhibitor 17-AAG Attenuates Aβ-Induced Synaptic Toxicity and Memory Impairment | Journal of Neuroscience
Nanomedicines Targeting Heat Shock Protein 90 Gene Expression in the Therapy of Breast Cancer - Zaib - 2022 - ChemistrySelect - Wiley Online Library
17-AAG - ABILITY, TOXICITY, SOLUBILITY
Tanespimycin (17-AAG) | HSP90 Inhibitor | MedChemExpress
The germline component of 17-AAG drug susceptibility. a... | Download Scientific Diagram
CLL Topics: 17AAG Clinical Trial
Tanespimycin (17-AAG) | ≥99%(HPLC) | Selleck | HSP (HSP90) inhibitor
17-AAG
Retaspimycin - an overview | ScienceDirect Topics
Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
